Study Suggests Hemodiafiltration Lowers Mortality Risk for Kidney Failure Patients

A multinational real-world evidence study by Fresenius Medical Care, published in the Journal of the American Society of Nephrology, found that high-volume hemodiafiltration is associated with a 28% lower relative risk of all-cause mortality compared to conventional high-flux hemodialysis. Analyzing nearly 20,000 patients across eight European countries, the findings support hemodiafiltration as a potential improved standard of care for individuals with kidney failure.